Cargando…
Dimeric Lectin Chimeras as Novel Candidates for Gb3-Mediated Transcytotic Drug Delivery through Cellular Barriers
Receptor-mediated transcytosis is an elegant and promising strategy for drug delivery across biological barriers. Here, we describe a novel ligand–receptor pair based on a dimeric, engineered derivative of the Pseudomonas aeruginosa lectin LecA, here termed Di-LecA, and the host cell glycosphingolip...
Autores principales: | Xu, Maokai, Antonova, Maria, Salavei, Pavel, Illek, Katharina, Meléndez, Ana Valeria, Omidvar, Ramin, Thuenauer, Roland, Makshakova, Olga, Römer, Winfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864468/ https://www.ncbi.nlm.nih.gov/pubmed/36678854 http://dx.doi.org/10.3390/pharmaceutics15010225 |
Ejemplares similares
-
Differential recognition of lipid domains by two Gb3-binding lectins
por: Schubert, Thomas, et al.
Publicado: (2020) -
A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells
por: Tomisch, Jana, et al.
Publicado: (2023) -
Structural Diversities of Lectins Binding to the Glycosphingolipid Gb3
por: Siukstaite, Lina, et al.
Publicado: (2021) -
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
por: Meléndez, Ana Valeria, et al.
Publicado: (2022) -
Novel perspectives on the transcytotic route in osteoclasts
por: Hirvonen, Mirkka J, et al.
Publicado: (2013)